Clinical Trial Update: A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 dose-escalation trial assessing safety and efficacy of CB-03-01 cream in facial acne vulgaris has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• CB-03-01 cream

Snippet

Sponsor: Intrepid Therapeutics, Inc. | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2020-11-16